Coming Soon

Season 1: Network Effects
Unlock exponential growth
Master the 16 network effects
20 years of insights in one class

Investing Profile

Peter Barrett

Photo of Peter Barrett, Partner at Atlas Venture

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
$500K - $5.0M
CompanyStageDateRound SizeTotal Raised
Obsidian Therapeutics
Series ADec 2017$50M
Indalo Therapeutics
Venture RoundAug 2017$9M
Co-investors: Ben Auspitz (F-Prime Capital Partners)
Series CMay 2017$42M
Series AJul 2014$29M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Daphne Teo (Nest.Bio Labs)
Seed RoundMar 2017$3M
Co-investors: Jerry Chen (Greylock), Robert Pollak (SV Angel), TJ Rylander (Next47), Sri Chandrasekar (Point72 Ventures), Jory Bell (Playground Global), Quin Garcia (AutoTech Ventures), Lip-Bu Tan (Walden International), Albert Azout (Cota Capital), Alex Ferrara (Bessemer Venture Partners), Jeremy Fiance (The House Fund), Andy Chou (11.2 Capital), Ali Partovi (Neo), Steve Blank (M34 Capital), Jerry Fiddler, Hadi Partovi
JenaValve Technology
Series CAug 2015$27M
Series CApr 2014$10M
Series CJul 2013$63M
Co-investors: Andrew Hack (Bain Capital Life Sciences), Olivier Litzka (Andera Partners)
Raze Therapeutics
Series AOct 2014$24M
Co-investors: Reza Halse (RA Capital), Hakan Goker (M Ventures (Merck)), Jason Rhodes (Atlas Venture)
Harbour Antibodies
Series AJul 2013€2.5M
Cadent Therapeutics
Series AJun 2013$6M